| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 4.324 | 20.049 | 19.746 | 8.218 | 6.040 | 16.397 | 10.256 | - |
| Total Income - EUR | - | - | 4.324 | 20.049 | 19.746 | 8.218 | 6.041 | 16.397 | 10.256 | - |
| Total Expenses - EUR | - | - | 6.528 | 1.885 | 1.506 | 3.633 | 1.975 | 3.802 | 2.867 | - |
| Gross Profit/Loss - EUR | - | - | -2.203 | 18.164 | 18.240 | 4.585 | 4.066 | 12.595 | 7.388 | - |
| Net Profit/Loss - EUR | - | - | -2.333 | 17.562 | 17.647 | 4.339 | 3.885 | 12.103 | 6.191 | - |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
Check the financial reports for the company - Eyedrops Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 22 | 716 | 534 | 1.191 | 790 | 418 | 164 | - |
| Current Assets | - | - | 2.062 | 14.900 | 32.309 | 35.783 | 38.805 | 51.269 | 10.637 | - |
| Inventories | - | - | 0 | 0 | 0 | 40 | 138 | 139 | 158 | - |
| Receivables | - | - | 1.014 | 0 | 1.380 | 1.354 | 0 | 0 | 1.057 | - |
| Cash | - | - | 1.048 | 14.900 | 30.928 | 34.388 | 38.667 | 51.130 | 9.422 | - |
| Shareholders Funds | - | - | -2.289 | 15.315 | 32.666 | 36.385 | 39.463 | 51.688 | 6.239 | - |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | - | - | 4.374 | 301 | 177 | 588 | 132 | -1 | 4.561 | - |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5911 - 5911" | |||||||||
| CAEN Financial Year |
5911
|
|||||||||
Comments - Eyedrops Srl